Showing results (31-40 of 283) with videos related to
Sort By:
Pageof 29
Expert Opinion on Drug Safety|July 28, 2020
Safety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphomaShinichi Makita, Rika Hosoba, Kensei TobinaiAdvances in Therapy|February 8, 2018
A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment StrategiesOlivier Hermine, Juan Carlos Ramos, Kensei TobinaiPlos One|August 19, 2020
Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphomaSaaya Tsutsué, Kensei Tobinai, Jingbo Yi, et al.Future Oncology (London, England)|October 6, 2020
Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database studySaaya Tsutsué, Kensei Tobinai, Jingbo Yi, et al.International Journal of Hematology|October 4, 2016
Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphomaWataru Munakata, Ken Ohashi, Nobuhiko Yamauchi, et al.Drugs in Context|March 1, 2019
Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challengesShinichi Makita, Katsuaki Imaizumi, Saiko Kurosawa, et al.Abdominal Imaging|April 17, 2009
Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CTUkihide Tateishi, Takashi Terauchi, Tomio Inoue, et al.Japanese Journal of Clinical Oncology|December 8, 2011
Lymphoma study group of JCOGKunihiro Tsukasaki, Kensei Tobinai, Tomomitu Hotta, et al.Leukemia & Lymphoma|June 16, 2020
Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysisJun Zhu, Ee Min Yeoh, Yoshinobu Maeda, et al.Advances in Therapy|December 23, 2016
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell MalignanciesKensei Tobinai, Christian Klein, Naoko Oya, et al.Pageof 29